CPI-300 regulatory update

FDA accepted for review an NDA from Cary for CPI-300 to treat major depressive disorder (MDD). The PDUFA date is Feb. 6, 2010. IntelGenx and Cary co-developed CPI-300 using IntelGenx's controlled-rele...